SOShinya Okada

Shinya Okada

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shinya Okada has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Primary Tumor Detected 11 Years After the Appearance of Mediastinal Lymph Node Cancer of Unknown Primary

    by Masaya Sogabe, Ryota Myobatake, Itsuki Saito, Shinya Okada, Hiroyoshi Tsubochi, Tomoyuki Nakano

    背景.原発巣が明らかでなく,肺門縦隔リンパ節のみに病巣を認める原発不明リンパ節癌を経験することが稀にある.症例.50歳,男性.X年に胃癌に対して幽門側胃切除術を施行.術前FDG-PETで大動脈下(LN#5)領域に11 mm大のFDG集積を伴うリンパ節を認めたが,生検は希望しなかった.X+1年にリンパ節は3 mmまで自然縮小,CEAは胃癌術前56.6 ng/mlから8.6 ng/mlまで低下した.しかしX+2年よりLN#5は緩徐に再増大,X+11年に24 mm大となり,CEAも1760.4 ng/mlまで上昇,新規に左肺S1+2に結節が出現したため手術の方針とした.胸腔鏡下にLN#5を摘出および左上大区域切除術を施行.病理診断は肺病変,LN#5は共に腺癌,免疫染色でTTF-1,napsin A陽性で肺原発を強く示唆する所見であった.11年後に出現した肺病変を原発巣とする肺癌および縦隔リンパ節転移と考え,pT1bN2M0 stage IIIAと診断した.結論.原発不明リンパ節癌は長期経過後に原発巣が出現する可能性があり,長期にわたる経過観察が重要であることを示唆する教訓的な症例であった.


  • Open Access

    Acute respiratory distress syndrome due to sepsis caused by Bacteroides ovatus after acute appendicectomy

    by Yoshinobu Fuse, Hironori Ohdaira, Teppei Kamada, Junji Takahashi, Keigo Nakashima, Yuichi Nakaseko, Norihiko Suzuki, Masashi Yoshida, Shinya Okada, Yutaka Suzuki

    Background: Appendicectomy is generally a minimally invasive surgery, after which postoperative complications such as acute respiratory distress syndrome (ARDS) are rare. We describe a case of ARDS due to sepsis caused by Bacteroides ovatus after appendicectomy. Case presentation: A man in his 60 s presented to our hospital with a chief complaint of right lower quadrant abdominal pain. He was diagnosed with acute appendicitis and underwent emergency laparoscopic appendicectomy. Cefmetazole was administered as a perioperative antibacterial drug. Postoperatively, the abdominal findings improved. However, on postoperative day three, bloody sputum and respiratory distress were observed. We performed thoracoabdominal computed tomography (CT) and observed bilateral pleural effusion and mottled frosted glass shadows extending to both lung fields. ARDS was diagnosed. We treated the patient with steroids and sivelestat sodium and switched the antibacterial drug to meropenem. The patient’s general condition improved. After the patient was treated, Bacteroides ovatus was isolated from preoperative blood culture, which was resistant to cefmetazole. Conclusions: We encountered a case in which ARDS due to sepsis was caused by Bacteroides ovatus after acute appendicectomy. Blood culture to isolate the causative organism and determine its antimicrobial sensitivity after commencement of empiric antibiotics is important even in common diseases, such as acute appendicitis.


  • Open Access

    Eosinophilic esophagitis induced by sublingual immunotherapy with cedar pollen: a case report

    by Daisuke Suto, Kazumoto Murata, Takaaki Otake, Eiichiro Ichiishi, Kiichi Sato, Shinya Okada, Mitsuhiro Okano, Yutaka Kohgo

    Eosinophilic esophagitis (EoE) is a chronic inflammatory disease associated with eosinophilic infiltration of the esophageal mucosa mostly due to exposure to allergens. However, the causes and pathogenesis of EoE are not fully understood. We encountered a case of EoE that was triggered by sublingual immunotherapy (SLIT) for cedar pollen allergy. A 40-year-old man who was treated with Japanese cedar pollen tablet SLIT for cedar pollen allergy developed heartburn 3 weeks after the initiation of the treatment. He took vonoprazan for the heartburn, but the heartburn did not improve. Then, esophagogastroduodenoscopy was performed; it revealed longitudinal furrows and white spots on the esophageal mucosa, decreased vascular permeability, and erosions. Consequently, the patient was diagnosed with EoE. Heartburn and chest discomfort disappeared 1 week after the discontinuation of Japanese cedar pollen tablet SLIT, and the patient tested positive for drug allergy to Japanese cedar pollen tablet SLIT. In this study, we found that if heartburn persists during SLIT for cedar pollen allergy, and does not improve on administration of vonoprazan or proton pump inhibitors, EoE should be suspected. In addition, the occurrence of EoE due to drug allergy is indicated.


  • Open Access

    Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report

    by Kuniyasu Takagi, Teppei Kamada, Yoshinobu Fuse, Wataru Kai, Junji Takahashi, Keigo Nakashima, Yuichi Nakaseko, Norihiko Suzuki, Masashi Yoshida, Shinya Okada, et al.

    Background: Metastatic neuroendocrine carcinoma has an extremely poor prognosis, and no effective second-line treatment is available. Herein, we describe a case of multiple metastases after primary resection of esophageal neuroendocrine carcinoma successfully treated with nivolumab plus radiotherapy in a short time. Case presentation: A man in his 70s presented to our hospital after an abnormality was detected on an upper gastrointestinal series. Upper gastrointestinal endoscopy revealed a type 2 tumor spanning the endothelial cell junction to the abdominal esophagus. Histopathological examination of the biopsy confirmed a diagnosis of esophageal neuroendocrine carcinoma. The patient had no distant metastases. Thoracoscopic esophagectomy with three-field lymph node dissection was performed. Histopathological examination confirmed a diagnosis of esophageal neuroendocrine carcinoma with features of adenoid cystic-like carcinoma and squamoid pattern (pT2 [MP], INF a, ly1, v1 [EVG], pIM0, pDM0, pRM0, pN1 [1/28], M0; Stage II), which was positive for synaptophysin. The postoperative course was good, with no complications. The patient was treated with 100 mg of irinotecan and 100 mg of cisplatin, administered every 4 weeks, as postoperative adjuvant chemotherapy. Grade 3 loss of appetite was observed, and adjuvant chemotherapy was discontinued after four cycles of first-line treatment. A positron emission tomography–computed tomography scan 3 years after surgery showed abnormal uptake in the subaortic, left hilar, and left axillary lymph nodes, and in a mass in the right lung apex. The patient was diagnosed with metastatic esophageal neuroendocrine carcinoma postoperatively. First-line treatment could not be repeated due to toxicity from the initial treatment. Nivolumab (240 mg every 2 weeks) was administered as second-line treatment, and radiotherapy was started (56 Gy delivered in 28 fractions to the local [subaortic and hilar] lymph nodes). After 10 cycles of nivolumab in combination with radiotherapy (56 Gy), a positron emission tomography–computed tomography scan showed disappearance of all lesions. A complete response was achieved. Maintenance therapy (240 mg of nivolumab) was continued. No recurrence has been observed for 42 months. Conclusions: We experienced a case in which nivolumab in combination with radiotherapy was effective for metastatic esophageal neuroendocrine carcinoma after primary resection.


  • Open Access

    Effect of Vitamin D Supplements on Relapse of Digestive Tract Cancer with Tumor Stromal Immune Response: A Secondary Analysis of the AMATERASU Randomized Clinical Trial

    by Taisuke Akutsu, Kazuki Kanno, Shinya Okada, Hironori Ohdaira, Yutaka Suzuki, Mitsuyoshi Urashima

    The aim was to examine whether vitamin D supplementation (2000 IU/day) reduces the risk of relapse in a subgroup of patients with digestive tract cancer, showing a sufficient immune response in tumor stroma by conducting secondary subgroup analyses of the AMATERASU randomized, double-blind, placebo-controlled trial (UMIN000001977). A total of 372 patients were divided into two subgroups stratified by the median density of immune cells infiltrating in tumor stroma into higher and lower halves. In the higher-half subgroup of CD56+ cells, the relapse ratio was significantly lower in the vitamin D group (7.4%) than in the placebo group (20.5%) (subdistribution hazard ratio (SHR), 0.35; 95% confidence interval (CI), 0.15–0.82), but it was equivalent (25.2% vs. 22.7%) in the lower-half subgroup of CD56+ cells (SHR, 1.21; 95% CI, 0.68–2.19) with a significant interaction (Pinteraction = 0.02). Although there were no significant differences, the risk of relapse was lower in the vitamin D group than in the placebo group in the higher half of CD45RO+ memory T cells (8.9% vs. 19.2%), and of CD8+ cytotoxic T cells (11.3% vs. 22.5%). In patients with digestive tract cancer, vitamin D supplementation was hypothesized to reduce the risk of relapse in the subgroup of patients who already have an adequate infiltration of immune cells in their tumor stroma.


  • Open Access

    Pembrolizumab plus platinum-based chemotherapy for unfavorable cancer of unknown primary site: Case report

    by Teppei Kamada, Hiroshi Ishiguro, Shinya Okada, Hideyuki Takeuchi, Junji Takahashi, Keigo Nakashima, Yuichi Nakaseko, Norihiko Suzuki, Hironori Ohdaira, Yutaka Suzuki

    Introduction: We report a case of sustained complete response in unfavorable cancer of unknown primary site (CUP) successfully treated with chemotherapy combining pembrolizumab, pemetrexed and platinum. Case presentation: A 66-year-old man was presented with weight loss and cough for 3 months. Contrast-enhanced computed tomography (CT) confirmed a mass in the superior anterior mediastinum and multiple enlarged mediastinal and axillary lymph nodes. Positron emission tomography-CT (PET-CT) showed abnormal uptake in the corresponding lesions. Histopathological analysis of the left axillary nodule revealed poorly differentiated adenocarcinoma. Immunohistochemistry showed the tumor cells were positive for cytokeratin 7 and thyroid transcription factor-1 and negative for cytokeratin 20. Thus, the patient was diagnosed as poorly differentiated adenocarcinoma of unknown primary, and treated as non-small-cell lung cancer. Additional genetic testing revealed the patient was negative for EGFR, ALK fluorescence in situ hybridization, ROS1, BRAF, and PD-L1 22C3 IHC with Tumor Proportion Score (TPS) was less than 1%. The patient received six cycles of pembrolizumab, platinum, and pemetrexed intravenously. Cisplatin was switched to carboplatin because of cisplatin nephrotoxicity in one course. PET-CT after six cycles showed all lesions disappeared; complete response was considered to have been achieved. Maintenance therapy of pembrolizumab and pemetrexed has been continued for 6 months after the induction therapies to prevent progressive disease. Complete response has been maintained. Discussion: Chemotherapy with pembrolizumab, platinum and pemetrexed could be valuable for treating unfavorable CUP. Conclusion: Chemotherapy with pembrolizumab, platinum, and pemetrexed helped achieved sustained complete response in a patient with unfavorable CUP.


  • Open Access

    Sequential Matrix Metalloproteinase-1 Expression Triggered by Infiltrating Monocytic Lineage Cells Modulates Pathophysiological Aspects of Human Nonalcoholic Steatohepatitis

    by Isao Okazaki, Shinsuke Shibata, Wataru Ando, Takayo Yanagawa, Hiroaki Yokomori, Akira Sonoda, Norihiko Suzuki, Eigoro Yamanouchi, Shinya Okada, Shinichi Kamikura, et al.

    Background/Aims: Matrix metalloproteinase-1 (MMP-1) is a key enzyme in collagen metabolism and tissue remodeling. We previously reported that MMP-1 expression in monocytes and other types of cells in the liver is associated with disease progression in patients with nonalcoholic steatohepatitis (NASH). To further implicate MMP-1 up-regulation in NASH pathogenesis, we examined dynamic and sequential MMP-1 expression in peripheral blood monocytes and cells in steatotic liver, and attempted to elucidate the mechanism of MMP-1 induction. Methods: Twenty-nine NASH patients and 26 non-NASH subjects were recruited in the study. Their peripheral blood mononuclear cells were isolated and analyzed by fluorescence-activated cell sorting, and liver specimens were subjected to confocal laser-scanning and immunoelectron microscopic examinations. Peripheral blood monocytic lineage cells were co-cultured with steatotic hepatocytes obtained from biopsy specimens to examine MMP-1 induction. Results: Infiltrating monocytes were the earliest to acquire an MMP-1-expressing phenotype among all investigated cell types in early-stage NASH liver. On the other hand, circulating monocytes did not express significant levels of MMP-1 mRNA or protein before infiltrating steatotic liver. Co-culture with steatotic hepatocytes induced MMP-1 expression in otherwise MMP-1-negative peripheral blood monocytic lineage cells. As disease progressed, MMP-1 was sequentially expressed by other types of cells in NASH liver. Notably, clusters of OV-6- or CK19-positive hepatic progenitor cells with a morphological feature of ductular reaction showed strong MMP-1 staining in advanced-stage NASH. Conclusion: MMP-1 up-regulation in infiltrating monocytic lineage cells represents an initial event in early-stage NASH and, together with the subsequent expression in other types of cells, modulates pathophysiological aspects of NASH.


  • Effect of Vitamin D on Relapse-Free Survival in a Subgroup of Patients with p53 Protein–Positive Digestive Tract Cancer: A Post Hoc Analysis of the AMATERASU Trial

    by Taisuke Akutsu, Shinya Okada, Shinichi Hirooka, Masahiro Ikegami, Hironori Ohdaira, Yutaka Suzuki, Mitsuyoshi Urashima

    Background: The AMATERASU randomized trial of vitamin D3 supplementation (2,000 IU/day; UMIN000001977) showed the potential benefit of vitamin D in a subgroup of patients with digestive tract cancer. By conducting post hoc analyses of this trial, we further explored whether subgroups stratified by expression levels of p53, vitamin D receptor (VDR), and Ki-67 modify the effect of vitamin D supplementation. Methods: The primary outcome was relapse-free survival (RFS). On IHC using pathologic specimens, the degree of p53 protein expression parallel with TP53 missense mutations was classified as p53 positive (>10%) and p53 negative (≤10%). In addition, VDR and Ki-67 expression levels were divided into quartiles. Results: The p53 status of 372 patients' pathologic specimens was evaluated. In a subgroup of patients with p53-positive cancer (n = 226), 5-year RFS was 79% in the vitamin D group, which was significantly higher than the 57% in the placebo group (HR, 0.52; 95% confidence interval, 0.31–0.88; P = 0.02). In the subgroup of patients with p53-negative cancer, 5-year RFS in the vitamin D group versus placebo group was 72% versus 84% (not significantly different), respectively. Effect modification by p53 positivity was significant (Pinteraction = 0.02). However, no significant effect modification by either VDR or Ki-67 was observed. Conclusions: These results generate a hypothesis that vitamin D supplementation may improve RFS in patients with p53-positive digestive tract cancer. Impact: The results are still preliminary, but potentially important, because TP53 is the most frequently mutated gene across cancers at all sites.


  • Open Access

    Effect Modification of Vitamin D Supplementation by Histopathological Characteristics on Survival of Patients with Digestive Tract Cancer: Post Hoc Analysis of the AMATERASU Randomized Clinical Trial

    by Hideyuki Yonaga, Shinya Okada, Taisuke Akutsu, Hironori Ohdaira, Yutaka Suzuki, Mitsuyoshi Urashima

    Some coauthors of this study previously performed the AMATERASU randomized, double-blind, placebo-controlled trial of postoperative oral vitamin D supplementation (2,000 IU/day) in 417 patients with stage I to III digestive tract cancer from the esophagus to the rectum who underwent curative surgery (UMIN000001977). We conducted a post-hoc analysis of the AMATERASU trial to explore the effects of modification of vitamin D supplementation by histopathological characteristics on survival. Among patients with poorly differentiated adenocarcinoma, the 5-year relapse-free survival rate of patients supplemented with vitamin D was 91% compared with 63% in the placebo group (hazard ratio [HR], 0.25; 95% confidence interval [CI], 0.08 to 0.78; P = 0.017; P for interaction = 0.023). Similarly, the 5-year overall survival rate was 92% in the vitamin D group compared with 72% in the placebo group (HR, 0.25; 95%CI, 0.07 to 0.94; P = 0.040; P for interaction = 0.012). In contrast, there were no significant effects in other histopathological characteristics between vitamin D and placebo groups. These findings generated the hypothesis that oral vitamin D supplementation may improve both relapse-free survival and overall survival in a subgroup of patients with poorly differentiated adenocarcinoma.


  • Characterization of Catalyst Inks By Rheology and Microscopic Particle Properties

    by Takahiro Suzuki, Shinya Okada, Shohji Tsushima

    Fundamental understanding of the state of catalyst inks and fabrication process is important to fabricate well-established catalyst layers of proton exchange membrane fuel cells (PEMFCs). The catalyst ink is a slurry which contains platinum-supported carbon and ionomer in a solvent. The state of the catalyst ink affects dynamics of materials during the fabrication process of the catalyst layer(1), and then the resultant structure(2). Additionally, the state of the catalyst ink can have time dependence, which means the procedure of particle agglomeration and sedimentation inside the slurry. Therefore, quantitative evaluation of the catalyst ink is required. In this study, a rheological measurement was conducted to characterize catalyst inks used to fabricate PEMFC catalyst layers. The rheological measurement can apply to opaque and high viscosity slurries like catalyst inks. Ionomer dispersion, pseudo-catalyst ink and catalyst ink with various ionomer content were measured to clarify the relationship between the rheological behavior and the types and amount of particles and interparticle interactions in the slurry. The rheological measurement was conducted by using a rheometer with a cone and plate system. Shear rate range was 200 to 3000 /s. The measurement temperature was 25°C. Downward measurement (from upper to lower shear rate) following the upward measurement was conducted. Ionomer dispersion (DE2020, Sigma-Aldrich), carbon black (Ketjenblack, Lion)–ionomer dispersion (pseudo-catalyst ink), and platinum-supported carbon (Pt/C, TEC10E50E, Tanaka Kikinzoku Kogyo)–ionomer dispersion (catalyst ink) were prepared. The volume fraction of carbon to the solvent (45wt.% 1-propanol aqueous solution) was 2% and ionomer to carbon ratio (I/C) was a parameter from 0.3 to 2.0. The viscosities of the slurries as a function of the shear rate are shown in Figure 1. The three types of the slurries showed quite different rheological properties with each other. The ionomer dispersions are Newtonian fluid in all I/C conditions from 0.3 to 2.0 (Fig. 1 (a)). On the other hand, pseudo-catalyst ink (Fig. 1 (b)) and catalyst ink (Fig. 1 (c)) were non-Newtonian fluid when I/C was low. The pseudo-catalyst ink showed a transition from non-Newtonian to Newtonian as I/C increased from 0.3 to 0.5. The ink also showed the transition from Newtonian to non-Newtonian as I/C increased from 1.0 to 2.0. The catalyst ink slightly showed non-Newtonian properties even in I/C 0.5 and 1.0. Additionally, the catalyst ink with I/C 0.3 and 0.5 showed relatively large hysteresis between the upward and downward measurements. The rheological property of the slurries can be the results of the state difference of the particles in the slurries such as the particle agglomeration and/or ionomer adsorption. The measurements of particle size distribution by dynamic light scattering and zeta potential were applied to the slurries (The results are not shown here). The comprehensive discussion to understand the state of the catalyst ink will be presented. Acknowledgments This work was supported by JSPS KAKENHI Grant Number 16K18028. References T. Suzuki, M. Kobayashi, H. Tanaka, M. Hayase and S. Tsushima, ECS Trans., 69, 465 (2015). W. K. Epting, J. Gelb and S. Litster, Adv. Funct. Mater., 22, 555 (2012). Figure 1